Angiodynamic Inc (NASDAQ: ANGO) is 10.84% higher on its value in year-to-date trading and has touched a low of $5.26 and a high of $9.58 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ANGO stock was last observed hovering at around $8.86 in the last trading session, with the day’s loss setting it -0.17%.
Currently trading at $8.69, the stock is 6.12% and 17.55% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.13 million and changing -1.92% at the moment leaves the stock 28.09% off its SMA200. ANGO registered 9.17% gain for a year compared to 6-month gain of 50.87%. The firm has a 50-day simple moving average (SMA 50) of $7.348 and a 200-day simple moving average (SMA200) of $6.76805.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 27.23% loss in the last 1 month and extending the period to 3 months gives it a 17.43%, and is -6.16% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.26% over the week and 5.16% over the month.
Angiodynamic Inc (ANGO) has around 748 employees, a market worth around $346.33M and $292.73M in sales. Profit margin for the company is -83.02%. Distance from 52-week low is 65.21% and -9.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-121.47%).
The EPS is expected to shrink by -5.26% this year.
Angiodynamic Inc (ANGO) Top Institutional Holders
185.0 institutions hold shares in Angiodynamic Inc (ANGO), with institutional investors hold 86.14% of the company’s shares. The shares outstanding are 41.00M, and float is at 38.70M with Short Float at 2.59%. Institutions hold 81.31% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 4.6 million shares valued at $27.86 million. The investor’s holdings represent 11.4443% of the ANGO Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 2.19 million shares valued at $13.25 million to account for 5.4418 of the shares outstanding. The other top investors are SYSTEMATIC FINANCIAL MANAGEMENT LP which holds 2.11 million shares representing 5.2432% and valued at over $12.76 million, while MILLENNIUM MANAGEMENT LLC holds 4.4576 of the shares totaling 1.79 million with a market value of $10.85 million.
Angiodynamic Inc (ANGO) Insider Activity
The most recent transaction is an insider purchase by Nighan Warren JR, the company’s SVP Quality and Regulatory. SEC filings show that Nighan Warren JR bought 768 shares of the company’s common stock on Oct 07 ’24 at a price of $6.09 per share for a total of $4677.0. Following the purchase, the insider now owns 45777.0 shares.
Angiodynamic Inc disclosed in a document filed with the SEC on Oct 10 ’24 that Nighan Warren JR (SVP Quality and Regulatory) bought a total of 100 shares of the company’s common stock. The trade occurred on Oct 10 ’24 and was made at $6.08 per share for $608.0. Following the transaction, the insider now directly holds 45877.0 shares of the ANGO stock.
Still, SEC filings show that on Oct 08 ’24, Trowbridge Stephen A (EVP and CFO) acquired 1,700 shares at an average price of $5.86 for $9962.0. The insider now directly holds 172,711 shares of Angiodynamic Inc (ANGO).
